News

Harmony Biosciences Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

PLYMOUTH MEETING, PA and CHICAGO, IL, August 21, 2020 — Harmony Biosciences Holdings, Inc. (“Harmony”), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet …

Read moreHarmony Biosciences Announces Closing of its Upsized Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares

Synthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology

Publication in peer-reviewed journal Science demonstrates the foundation of the company’s evolution-based, data-driven engineering technology to build artificial functional enzymes  Chicago, July 23, 2020 – A publication released in the peer-review journal Science today demonstrates the …

Read moreSynthetic Protein Design and Production Publication Confirms Evozyne’s Revolutionary Technology